日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immune checkpoint inhibitor rechallenge in advanced NSCLC: prognostic value of the neutrophil-to-lymphocyte ratio

晚期非小细胞肺癌患者再次接受免疫检查点抑制剂治疗：中性粒细胞与淋巴细胞比值的预后价值

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-1094
Minami, Soichiro; Yamazaki, Yusuke; Saito, Shin; Toi, Yukihiro; Fukuzawa, Keito; Doman, Tsuyoshi; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
肺癌
肿瘤
中性粒细胞
肿瘤免疫
粒细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Low serum albumin levels and the nongerminal center B-cell subtype according to the Hans algorithm as strong prognostic factors in ≥ 80-year-old patients with large B-cell lymphoma treated with rituximab-containing chemotherapy

对于接受含利妥昔单抗化疗的≥80岁大B细胞淋巴瘤患者，低血清白蛋白水平和根据Hans算法划分的非生发中心B细胞亚型是强有力的预后因素。

期刊:Annals of Hematology
影响因子:2.4
doi:10.1007/s00277-026-06818-3
Kawashima, Ichiro; Nakadate, Ayato; Hyuga, Hideto; Matsuura, Minori; Sakamoto, Yuma; Suzuki, Jun; Kumagai, Takuma; Suzuki, Megumi; Yamanda-Koshiishi, Megumi; Yamamoto, Takeo; Nakajima, Kei; Oishi, Naoki; Kondo, Tetsuo; Kirito, Keita
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Real-world outcomes and association between immune-related adverse events and therapeutic efficacy of nivolumab plus ipilimumab in elderly patients (≥75 years) with advanced non-small cell lung cancer

真实世界结果以及免疫相关不良事件与老年（≥75岁）晚期非小细胞肺癌患者接受纳武利尤单抗联合伊匹木单抗治疗疗效之间的关联

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-640
Minami, Soichiro; Doman, Tsuyoshi; Toi, Yukihiro; Fukuzawa, Keito; Yamazaki, Yusuke; Saito, Shin; Narumi, Akane; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Ono, Kana; Aiba, Tomoiki; Kawana, Sachiko; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

A case of lower respiratory tract infection caused by Pandoraea sputorum in a human T-lymphotropic virus type 1 carrier

一例由潘多拉菌（Pandoraea sputorum）引起的人类T淋巴细胞病毒1型携带者下呼吸道感染病例

期刊:IDCases
影响因子:1
doi:10.1016/j.idcr.2025.e02359
Ogasawara, Takahiro; Yamanda, Shinsuke; Fukuzawa, Keito; Yamazaki, Yusuke; Doman, Tsuyoshi; Minami, Soichiro; Narumi, Akane; Saito, Shin; Odaka, Tetsuo; Ono, Kana; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Toi, Yukihiro; Sugawara, Shunichi; Kimura, Yuichiro
炎症/感染
细胞生物学
微生物学
发表日期：2025
文献求助 收藏

Successful application of lorlatinib in a 23-year-old patient with anaplastic lymphoma kinase (ALK)-positive lung cancer and multiple brain metastases

劳拉替尼成功应用于一名23岁患有间变性淋巴瘤激酶（ALK）阳性肺癌和多发性脑转移的患者

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.1981
Murakami, Yosuke; Kawashima, Yosuke; Chiba, Shinji; Hara, Shuichiro; Yamazaki, Yusuke; Doman, Tsuyoshi; Saito, Shin; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Toi, Yukihiro; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
肺癌
肿瘤
肿瘤免疫
信号转导
ALK
淋巴瘤
神经科学
发表日期：2024
文献求助 收藏

The dorsal muscle group area at the T12 vertebral level as a risk factor for tolerability of nintedanib in patients with idiopathic pulmonary fibrosis or other progressive fibrosing interstitial lung diseases

T12椎体水平的背侧肌群面积是特发性肺纤维化或其他进行性纤维化间质性肺疾病患者对尼达尼布耐受性的危险因素。

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000038920
Ono, Manabu; Kobayashi, Seiichi; Masakazu, Hanagama; Ishida, Masatsugu; Sato, Hikari; Okutomo, Koji; Shirai, Yusuke; Takahashi, Kodai; Yamada, Mitsuhiro; Fujino, Naoya; Yamanda, Shinsuke; Yanai, Masaru
特发性肺纤维化
发表日期：2024
文献求助 收藏

Efficacy of paclitaxel-carboplatin with bevacizumab as a late-line therapy for patients with advanced nonsquamous non-small cell lung cancer: A platinum rechallenge

紫杉醇-卡铂联合贝伐单抗作为晚期非鳞状非小细胞肺癌患者一线治疗的疗效：铂类药物再挑战

期刊:Thoracic Cancer
影响因子:2.3
doi:10.1111/1759-7714.15107
Sugisaka, Jun; Toi, Yukihiro; Kawashima, Yosuke; Domeki, Yutaka; Aiba, Tomoiki; Kawana, Sachiko; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Association of immune-related pneumonitis with clinical benefit of anti-programmed cell death-1 monotherapy in advanced non-small cell lung cancer

免疫相关性肺炎与晚期非小细胞肺癌抗程序性细胞死亡蛋白-1单药治疗的临床获益相关

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.4045
Ono, Kana; Ono, Hirotaka; Toi, Yukihiro; Sugisaka, Jun; Aso, Mari; Saito, Ryohei; Kawana, Sachiko; Aiba, Tomoiki; Odaka, Tetsuo; Matsuda, Suguru; Saito, Shin; Narumi, Akane; Ogasawara, Takahiro; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi
肺炎
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2021
文献求助 收藏

COMPLICATIONS OF HIGH-DOSE STEROIDS IN COVID-19

新冠肺炎患者使用高剂量类固醇的并发症

期刊:Cancer Reports
影响因子:1.9
doi:10.1002/cnr2.2145
Minami, Soichiro; Kawashima, Yosuke; Munakata, Yasuhiko; Matsuno, Masahiro; Hara, Shuichiro; Yamazaki, Yusuke; Doman, Tsuyoshi; Saito, Shin; Odaka, Tetsuo; Ogasawara, Takahiro; Shimizu, Hisashi; Sugisaka, Jun; Aiba, Tomoiki; Toi, Yukihiro; Yamanda, Shinsuke; Kimura, Yuichiro; Sugawara, Shunichi; KAUR, TANISHA; BHATTI, WAQAS
肺炎
新冠
微生物学
发表日期：2021
文献求助 收藏

Association Between Skin Reaction and Clinical Benefit in Patients Treated with Anti-Programmed Cell Death 1 Monotherapy for Advanced Non-Small Cell Lung Cancer

晚期非小细胞肺癌患者接受抗程序性细胞死亡蛋白1单药治疗时，皮肤反应与临床获益之间的关联

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0550
Aso, Mari; Toi, Yukihiro; Sugisaka, Jun; Aiba, Tomoiki; Kawana, Sachiko; Saito, Ryohei; Ogasawara, Takahiro; Tsurumi, Kyoji; Ono, Kana; Shimizu, Hisashi; Domeki, Yutaka; Terayama, Keisuke; Kawashima, Yosuke; Nakamura, Atsushi; Yamanda, Shinsuke; Kimura, Yuichiro; Honda, Yoshihiro; Sugawara, Shunichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏